T1	PROC 933 957	Escala Rankin modificada
#1	AnnotatorNotes T1	C3888574; Modified Rankin score; Diagnostic Procedure
T2	CHEM 75 86	riboflavina
#2	AnnotatorNotes T2	C0035527; riboflavin; Organic Chemical · Pharmacologic Substance · Vitamin
T3	CHEM 1276 1287	carbomicina
T4	DISO 97 110	daño neuronal
T5	DISO 128 149	ictus isquémico agudo
#3	AnnotatorNotes T5	C5392833; Acute Ischemic Stroke; Disease or Syndrome
T6	PROC 924 929	NIHSS
#4	AnnotatorNotes T6	C3472497; Assessment using National Institutes of Health stroke scale; Health Care Activity
T7	CHEM 316 327	riboflavina
#5	AnnotatorNotes T7	C0035527; riboflavin; Organic Chemical · Pharmacologic Substance · Vitamin
T8	CHEM 328 339	vitamina B2
#6	AnnotatorNotes T8	C0035527; riboflavin; Organic Chemical · Pharmacologic Substance · Vitamin
T9	DISO 358 379	ictus isquémico agudo
#7	AnnotatorNotes T9	C5392833; Acute Ischemic Stroke; Disease or Syndrome
T10	CHEM 431 440	glutamato
#8	AnnotatorNotes T10	C0017789; Glutamates; Amino Acid, Peptide, or Protein | C0220839; glutamate; Amino Acid, Peptide, or Protein · Biologically Active Substance
T11	DISO 465 470	Ictus
#9	AnnotatorNotes T11	C0038454; Cerebrovascular accident; Disease or Syndrome
T12	DISO 497 518	Ictus isquémico agudo
#10	AnnotatorNotes T12	C5392833; Acute Ischemic Stroke; Disease or Syndrome
T13	DISO 724 729	ictus
#11	AnnotatorNotes T13	C0038454; Cerebrovascular accident; Disease or Syndrome
T14	DISO 968 973	ictus
#12	AnnotatorNotes T14	C0038454; Cerebrovascular accident; Disease or Syndrome
T15	PROC 669 693	consentimiento informado
#13	AnnotatorNotes T15	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T16	DISO 1068 1078	Desórdenes
#14	AnnotatorNotes T16	C0012634; Disease; Disease or Syndrome
T17	PROC 1163 1174	tratamiento
#15	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	CHEM 1191 1217	antidepresivos tricíclicos
#16	AnnotatorNotes T18	C0003290; Tricyclic Antidepressive Agents; Pharmacologic Substance
T19	CHEM 1233 1247	estreptomicina
#17	AnnotatorNotes T19	C0038425; streptomycin; Antibiotic · Organic Chemical
T20	CHEM 1249 1261	eritromicina
#18	AnnotatorNotes T20	C0014806; erythromycin; Antibiotic · Organic Chemical
T21	CHEM 1263 1274	tirotricina
#19	AnnotatorNotes T21	C0041499; tyrothricin; Amino Acid, Peptide, or Protein · Antibiotic
T22	CHEM 1290 1302	tetraciclina
#20	AnnotatorNotes T22	C0039644; tetracycline; Antibiotic · Organic Chemical | C0039651; Tetracyclines; Chemical Viewed Structurally | C1744619; Tetracycline Antibiotics; Antibiotic · Organic Chemical
T23	ANAT 102 110	neuronal
#21	AnnotatorNotes T23	C0027882; Neurons; Cell
T24	PROC 173 264	Ensayo clínico aleatorizado, con dos grupos paralelos, doble ciego y controlado con placebo
T25	CHEM 1219 1231	fenotiazidas
T26	PROC 287 301	administración
#22	AnnotatorNotes T26	C1533734; Administration procedure; Therapeutic or Preventive Procedure
T27	PROC 1020 1037	pruebas de imagen
#23	AnnotatorNotes T27	C0011923; Diagnostic Imaging; Diagnostic Procedure
T28	CHEM 1179 1189	probenecid
#24	AnnotatorNotes T28	C0033209; probenecid; Organic Chemical · Pharmacologic Substance
T29	Date 13 17	2014
T31	LIVB 114 123	pacientes
#25	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group
T33	LIVB 344 353	pacientes
#26	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 547 556	Pacientes
#27	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	Age 557 575	mayores de 18 años
T36	LIVB 583 590	hombres
#28	AnnotatorNotes T36	C0025266; Male population group; Population Group
T37	LIVB 596 603	mujeres
#29	AnnotatorNotes T37	C0043210; Woman; Population Group
T38	LIVB 608 616	Paciente
#30	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	LIVB 619 638	representante legal
#31	AnnotatorNotes T39	C4288823; Legal Representative for the Study; Human
T40	LIVB 698 707	Pacientes
#32	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	Spec_cue 712 723	sospecha de
T42	Duration 733 749	menos de 3 horas
T43	LIVB 792 814	Mujeres en edad fértil
#33	AnnotatorNotes T43	C4324275; Woman of childbearing potential; Population Group
T44	Age 803 814	edad fértil
T46	Spec_cue 820 839	riesgo potencial de
T48	PHYS 840 848	embarazo
#34	AnnotatorNotes T48	C0032961; Pregnancy; Organism Function
T49	PHYS 851 862	amamantando
#35	AnnotatorNotes T49	C0006147; Breast Feeding; Organism Function
T50	LIVB 866 875	Pacientes
#36	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T30	PHYS 648 656	entender
#37	AnnotatorNotes T30	C0162340; Comprehension; Mental Process
T32	Neg_cue 981 994	Imposibilidad
A1	Assertion T13 Speculated
A2	Population_data T43 Age
A3	Assertion T48 Speculated
A5	Assertion T27 Negated
A4	Status T16 History_of
#38	AnnotatorNotes T24	C0206034; Clinical Trials, Randomized; Research Activity + C2826345; Parallel Study; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#39	AnnotatorNotes T25	C0031434; phenothiazine; Organic Chemical · Pharmacologic Substance 
#40	AnnotatorNotes T3	C0054700; carbomycin; Organic Chemical · Antibiotic 
T45	Spec_cue 1091 1097	puedan
T47	CONC 1098 1108	interferir
A6	Assertion T47 Speculated
#41	AnnotatorNotes T47	C0521102; Interferes with; Functional Concept
R2	Speculation Arg1:T45 Arg2:T47	
#42	AnnotatorNotes T4	C1709216; Neural Tissue Damage; Injury or Poisoning (?)
R3	Experiences Arg1:T31 Arg2:T2	
T51	Spec_cue 69 71	si
T52	CONC 87 93	reduce
A7	Assertion T52 Speculated
#43	AnnotatorNotes T52	C0547047; Decrease; Quantitative Concept
R4	Speculation Arg1:T51 Arg2:T52	
R5	Before Arg1:T2 Arg2:T52	
R6	Location_of Arg1:T23 Arg2:T4	
R7	Experiences Arg1:T31 Arg2:T5	
R8	Causes Arg1:T5 Arg2:T4	
R9	Experiences Arg1:T31 Arg2:T4	
R10	Used_for Arg1:T7 Arg2:T26	
R11	Used_for Arg1:T8 Arg2:T26	
R12	Experiences Arg1:T33 Arg2:T26	
R13	Experiences Arg1:T33 Arg2:T9	
T53	CONC 392 401	reducción
A8	Assertion T53 Speculated
#44	AnnotatorNotes T53	C0547047; Decrease; Quantitative Concept
T54	Spec_cue 281 283	si
R14	Speculation Arg1:T54 Arg2:T53	
R15	Before Arg1:T26 Arg2:T53	
T55	DISO 405 418	excitoxicidad
R16	Causes Arg1:T10 Arg2:T55	
R17	Experiences Arg1:T33 Arg2:T55	
R18	Causes Arg1:T9 Arg2:T55	
R19	Has_Age Arg1:T34 Arg2:T35	
R20	Has_Age Arg1:T36 Arg2:T35	
R21	Has_Age Arg1:T37 Arg2:T35	
R22	Experiences Arg1:T39 Arg2:T30	
R23	Overlap Arg1:T30 Arg2:T15	
R24	Experiences Arg1:T38 Arg2:T30	
R25	Experiences Arg1:T40 Arg2:T13	
R26	Speculation Arg1:T41 Arg2:T13	
R27	Has_Duration_or_Interval Arg1:T13 Arg2:T42	
R28	Has_Age Arg1:T43 Arg2:T44	
R30	Speculation Arg1:T46 Arg2:T48	
R31	Experiences Arg1:T43 Arg2:T49	
T56	Result_or_Value 906 909	? 2
R32	Has_Result_or_Value Arg1:T6 Arg2:T56	
R33	Experiences Arg1:T50 Arg2:T6	
T57	Result_or_Value 974 977	? 2
R34	Has_Result_or_Value Arg1:T1 Arg2:T57	
R35	Before Arg1:T1 Arg2:T14	
R36	Negation Arg1:T32 Arg2:T27	
T58	PROC 1057 1064	estudio
#45	AnnotatorNotes T58	C0008976; Clinical Trials; Research Activity
R37	Before Arg1:T27 Arg2:T58	
T59	CONC 1115 1157	interpretación de las escalas neurológicas
#46	AnnotatorNotes T59	C3258196; Stroke scale overall interpretation; Intellectual Product (?)
R38	Used_for Arg1:T28 Arg2:T17	
R39	Used_for Arg1:T18 Arg2:T17	
R40	Used_for Arg1:T25 Arg2:T17	
R41	Used_for Arg1:T19 Arg2:T17	
R42	Used_for Arg1:T20 Arg2:T17	
R43	Used_for Arg1:T21 Arg2:T17	
R44	Used_for Arg1:T3 Arg2:T17	
R45	Used_for Arg1:T22 Arg2:T17	
T60	CONC 1323 1332	inclusión
#47	AnnotatorNotes T60	C1512693; Inclusion; Qualitative Concept
R46	Overlap Arg1:T17 Arg2:T60	
#48	AnnotatorNotes T55	C1709216; Neural Tissue Damage; Injury or Poisoning (?)
R29	Experiences Arg1:T43 Arg2:T48	
A9	Experiencer T31 Patient
A10	Experiencer T33 Patient
A11	Experiencer T37 Patient
A12	Experiencer T36 Patient
A13	Experiencer T34 Patient
A14	Experiencer T38 Patient
A15	Experiencer T40 Patient
A16	Experiencer T43 Patient
A17	Experiencer T50 Patient
A18	Experiencer T39 Other
